following successful phase ii clinical studies with praziquantel ( 2-cyclohexylcarbonyl-1,2,3,6,7,11b-hexahydro-4h-pyrazino [ 2,1-a ] isoquinolin-4-one , embay 8440 , biltricide ) , expanded field trials of phase iii were conducted in mindoro oriental , leyte and davao norte , to reassess efficacy , safety and acceptability of the drug on a larger scale .
C0032911
praziquantel
C0702014
biltricide